Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lam, P. P.L.
Right arrow Articles by Gaisano, H. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lam, P. P.L.
Right arrow Articles by Gaisano, H. Y.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:2744-2754, 2005
© 2005 by the American Diabetes Association, Inc.

Transgenic Mouse Overexpressing Syntaxin-1A as a Diabetes Model

Patrick P.L. Lam1,2, Yuk-Man Leung1,2, Laura Sheu1,2, James Ellis3, Robert G. Tsushima1,2, Lucy R. Osborne1,4, and Herbert Y. Gaisano1,2

1 Department of Medicine, University of Toronto, Toronto, Canada
2 Department of Physiology, University of Toronto, Toronto, Canada
3 Program in Developmental Biology, Sick Kids Hospital, Toronto, Canada
4 Department of Molecular and Medical Genetics, University of Toronto, Toronto, Canada

Soluble N-ethylmaleimide–sensitive factor (NSF) attachment protein receptor (SNARE) protein syntaxin-1A (STX-1A) plays a role not only in exocytosis, but also binds and regulates Ca2+ and K+ (voltage-gated K+ and ATP-sensitive K+ channels) to influence the sequence of events leading to secretion. Islet levels of STX-1A and cognate SNARE proteins are reduced in type 2 diabetic rodents, suggesting their role in dysregulated insulin secretion contributing to the abnormal glucose homeostasis. We investigated the specific role of STX-1A in pancreatic ß-cells by generating transgenic mice, which express a moderately increased level (~30% higher) of STX-1A in pancreatic islets (hereafter called STX-1A mice). The STX-1A mice displayed fasting hyperglycemia and a more sustained elevation of plasma glucose levels after an intraperitoneal glucose tolerance test, with correspondingly reduced plasma insulin levels. Surprisingly, ß-cells from the STX-1A male mice also exhibited abnormal insulin tolerance. To unequivocally determine the ß-cell secretory defects, we used single-cell analyses of exocytosis by patch clamp membrane capacitance measurements and ion channel recordings. Depolarization-evoked membrane capacitance increases were reduced in the STX-1A mouse islet ß-cells. The STX-1A mouse also exhibited reduced currents through the Ca2+ channels but little change in the voltage-gated K+ channel or ATP-sensitive K+ channel. These results suggest that fluctuation of islet STX-1A levels in diabetes could influence the pathological and differential regulation of ß-cell ion channels and the exocytotic machinery, collectively contributing to the impaired insulin secretion.


Address correspondence and reprint requests to Herbert Y. Gaisano, MD, University of Toronto, Room 7226, Medical Science Building, 1 King’s College Circle, Toronto, Ontario, Canada M5S 1A8. E-mail: herbert.gaisano{at}utoronto.ca. Or Lucy R. Osborne, PhD, University of Toronto, Room 7238, Medical Science Building, 1 King’s College Circle, Toronto, Ontario, Canada M5S 1A8. E-mail: lucy.osborne{at}utoronto.ca

Abbreviations: Cm, membrane capacitance; GST, glutathione S-transferase; IPGTT, intraperitoneal glucose tolerance test; KATP channel, ATP-sensitive K+ channel; Kv channel, voltage-gated potassium channel; NSF, N-ethylmaleimide–sensitive factor; SNAP-25, synaptosome-associated protein of 25 kDa; SNARE, soluble NSF attachment protein receptor; STX-1A, syntaxin-1A; TEA, tetraethylammonium; VAMP-2, vesicle-associated membrane protein 2; WBS, Williams-Beuren syndrome


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
B. Ng, Y. Kang, C. L. Elias, Y. He, H. Xie, J. B. Hansen, P. Wahl, and H. Y. Gaisano
The Actions of a Novel Potent Islet {beta}-Cell Specific ATP-Sensitive K+ Channel Opener Can Be Modulated by Syntaxin-1A Acting on Sulfonylurea Receptor 1
Diabetes, August 1, 2007; 56(8): 2124 - 2134.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
M. Ohara-Imaizumi, T. Fujiwara, Y. Nakamichi, T. Okamura, Y. Akimoto, J. Kawai, S. Matsushima, H. Kawakami, T. Watanabe, K. Akagawa, et al.
Imaging analysis reveals mechanistic differences between first- and second-phase insulin exocytosis
J. Cell Biol., May 21, 2007; 177(4): 695 - 705.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Yang, P. Xu, Y. Xiao, X. Xiong, and T. Xu
Domain Requirement for the Membrane Trafficking and Targeting of Syntaxin 1A
J. Biol. Chem., June 2, 2006; 281(22): 15457 - 15463.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. P. Kwan, L. Xie, L. Sheu, C. J. Nolan, M. Prentki, A. Betz, N. Brose, and H. Y. Gaisano
Munc13-1 Deficiency Reduces Insulin Secretion and Causes Abnormal Glucose Tolerance.
Diabetes, May 1, 2006; 55(5): 1421 - 1429.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. A. Spurlin and D. C. Thurmond
Syntaxin 4 Facilitates Biphasic Glucose-Stimulated Insulin Secretion from Pancreatic {beta}-Cells
Mol. Endocrinol., January 1, 2006; 20(1): 183 - 193.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.